Viking Therapeutics is trading at $36.21 (-4.23%) as a broad biotech and growth-stock selloff pressures the sector, moving in line with wider weakness in risk assets.
- The move appears driven by market sentiment rather than company-specific news, with the XBI biotech ETF down 2.00% and the Nasdaq also trading lower.
- No major announcements, earnings updates, or regulatory events have been reported for the company today.